MiMedx Group Inc (NASDAQ:MDXG)

4.06
BATS BZX Real-Time Price
As of 10:57am ET
 -0.015 / -0.37%
Today’s Change
2.43
Today|||52-Week Range
5.51
+45.86%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Medical Specialties
MARKET CAP
$420.6M

Company Description

MiMedx Group, Inc. is a therapeutic biologics company, which engages in the design, manufacture, and marketing of products, and tissue processing services. It serves the wound care, burn, surgical, orthopedic, spine, sports medicine, ophthalmic, and dental sectors of healthcare. Its biomaterial platform technologies include AmnioFix and EpiFix, a tissue allografts derived from amnion and chorion layers of human placental membrane, EpiCord and AmnioCord, a tissue allografts derived from umbilical cord tissue, and AmnioFill, a placental connective tissue matrix derived from the placental disc and other placental tissue. The company was founded on July 30, 1985 and is headquartered in Marietta, GA.

Contact Information

MiMedx Group, Inc.
1775 West Oak Commons Court NE
Marietta Georgia 30062
P:(770) 651-9100
Investor Relations:

Employees

Shareholders

Individual stakeholders27.91%
Other institutional23.92%
Mutual fund holders18.79%

Top Executives

Joe CapperChief Executive Officer & Director
Ricci S. WhitlowChief Operating Officer & Executive Vice President
Peter M. CarlsonChief Financial Officer
David H. MasonChief Medical Officer
Mark P. GravesChief Compliance Officer & Senior VP